Multiple sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease of the
central nervous system (CNS). 1, 2 MS attacks the myelinated axons in the CNS, destroying …

Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease of the
central nervous system. It affects approximately 400,000 people in the United States and …

Multiple sclerosis (MS) is an immune-inflammatory disease that attacks and damages
myelinated axons in the central nervous system (CNS) and causes nontraumatic …

The cause of multiple sclerosis (MS) and its pathogenesis are unknown, but 2 main theories
have emerged: a viral cause and an autoimmune cause. In the past half century, however …

Multiple sclerosis (MS) is a potentially disabling chronic autoimmune neurological disease
that mainly affects young adults. Our understanding of the pathophysiology of MS has …

Multiple sclerosis (MS), the most common disabling neurologic disease of young people,
afflicts approximately a quarter of a million Americans. The symptoms of MS result from …

The development of immunomodulatory therapies for multiple sclerosis (MS) has had
significant impact in altering the natural history of the disease. Although these agents reduce …

Although the earliest recorded description of multiple sclerosis (MS) dates back to the 14 th
century, it was not until the latter years of the 20 th that treatments for this disabling condition …

New drugs for multiple sclerosis: new treatment algorithms : Current Opinion in Neurology
New drugs for multiple sclerosis: new treatment algorithms : Current Opinion in Neurology Log …

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system
(CNS) in which inflammation, demyelination, and axonal loss occurs from the very early …